text January 25, 2023Muscular Dystrophy Association’s Venture Philanthropy Program Announces Investment in Non-viral Gene Therapy
text January 25, 2023PPMD Invests $500,000 in Myosana Therapeutics to Advance Non-Viral Gene Therapy Platform
text August 26, 2021Parent Project Muscular Dystrophy Invests $350,480 in Myosana Therapeutics to Support Non-Viral Gene Therapy Development